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Sirtuin 1 (Sirt1) is an NAD-dependent class III deacetylase that functions as a cellular energy sensor.
In addition to its well-characterized effects in peripheral tissues, evidence suggests that SIRT1 in
neurons plays a role in the central regulation of energy balance and reproduction, but no studies
have addressed the contribution of astrocytes. We show here that overexpression of SIRT1 in
astrocytes causes markedly increased food intake, body weight gain, and glucose intolerance, but
expression of a deacetylase-deficient SIRT1 mutant decreases food intake and body weight and
improves glucose tolerance, particularly in female mice. Paradoxically, the effect of these SIRT1
mutants on insulin tolerance was reversed, with overexpression showing greater insulin sensitivity.
The mice overexpressing SIRT1 were more active, generated more heat, and had elevated oxygen
consumption, possibly in compensation for the increased food intake. The female overexpressing
mice were also more sensitive to diet-induced obesity. Reproductively, the mice expressing the
deacetylase-deficient SIRT1 mutant had impaired estrous cycles, decreased LH surges, and fewer
corpora lutea, indicating decreased ovulation. The GnRH neurons were responsive to kisspeptin
stimulation, but hypothalamic expression of Kiss1 was reduced in the mutant mice. Our results
showed that SIRT1 signaling in astrocytes can contribute to metabolic and reproductive regulation
independent of SIRT1 effects in neurons. (Endocrinology 160: 1547–1560, 2019)
Sirtuin 1 (Sirt1) was first identified as a mammalianhomolog of the yeast silent information regulator 2
(Sir2) protein, which is essential for lifespan extension
due to caloric restriction. The sirtuins are class III histone
deacetylases that need NAD1 for enzyme activity (1),
and these enzymes function as cellular energy sensors
sensitive to the intracellular NAD1/NADH ratio. Sirt1 is
activated during fasting or caloric restriction to increase
fatty acid oxidation and gluconeogenesis and suppress
insulin secretion, insulin action, and adipogenesis (1–3).
SIRT1 is ubiquitously expressed and has many important
functions in peripheral metabolic tissues, including adi-
pose tissue, liver, and muscle, that underlie its role in
sensing energy balance (2, 4–6). Global knockouts are
difficult to interpret because most mice die in utero or
perinatally (7–9), and loss of the deacetylase enzyme
activity mimics many of the effects of the knockout
(10–12), suggesting that the majority, but not all, of
SIRT1 function is related to its enzyme activity. Re-
production is a very energy-demanding process, so it is
repressed under conditions of negative energy balance
that may be triggered by famine, eating disorders such as
anorexia and bulimia, and prolonged high-intensity ex-
ercise in humans (13, 14). A role for SIRT1 in regulating
reproduction has been postulated, but conflicting results
have been obtained. SIRT1 is expressed in spermatogonia
and is necessary for normal spermatogenesis in males
(15, 16). In females, SIRT1 is expressed in large ovarian
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follicles, particularly in the oocyte and granulosa cells,
and loss of SIRT1 causes small ovaries with early-stage
follicular development but no evidence of ovulation
(8, 17).
SIRT1 also plays a central role in preventing neuronal
injury in ischemic stroke, Alzheimer’s disease, brain in-
jury, and neurodegeneration, possibly by reducing neu-
roinflammation (18–22), and SIRT1 expression and
activity increase in the hypothalamus with fasting
(23–25). Brain-specific deletion of Sirt1 in progenitor
cells using Nestin-cre decreases anxiety and depressive-
like behavior (19, 21). We recently reported that over-
expression of SIRT1 in neurons impaired ovulation and
estrous cycles, consistent with reproductive suppres-
sion, but impaired rather than increased glucose toler-
ance (26). Expression of the deacetylase-deficient SIRT1
mutant had the opposite effects and was consistent with a
previous report that loss of SIRT1 deacetylase function in
neurons increased hypothalamic insulin signaling and
improved peripheral insulin sensitivity. Genetic manip-
ulation of Sirt1 in specific neurons has produced con-
flicting results. Deletion of Sirt1 in pro-opiomelanocortin
(POMC) neurons decreases energy expenditure and in-
creases susceptibility to diet-induced obesity (DIO) in
mice (27), but deletion in Agouti-related peptide (AgRP)
neurons has the opposite effect, consistent with the op-
posing roles of these two neuronal populations (28, 29).
Mice lacking Sirt1 in Sf1-expressing neurons have in-
creased susceptibility to DIO and insulin resistance,
primarily because of decreased energy expenditure and
skeletal muscle insulin sensitivity, and transgenic over-
expression prevents these effects (30). Thus, Sirt1 in
different neuronal populations may play distinct and
sometimes even opposing roles in the regulation of energy
balance.
Glial cells make up 50% of the cells in the central
nervous system, but their role in metabolic and re-
productive regulation has been largely overlooked
(31–33). Astrocytes, the most abundant glial cell, may
play a passive role by clearing synaptic potassium
and neurotransmitters and support neuronal function
(34–36), but recent evidence has shown that astrocytes
may also play an active role. Insulin signaling in astro-
cytes controls glucose-induced activation of POMC
neurons (37), and leptin signaling in astrocytes controls
feeding and obesity (38). Furthermore, astrocyte in-
flammation is involved in promoting weight gain
after high-fat diet feeding because loss of nuclear fac-
tor kB (NF-kB) signaling reduces food intake and in-
creases energy expenditure (39), and loss of peroxisome
proliferator–activated receptor-g signaling in astrocytes
impaired glucose tolerance and caused hepatic steatosis
(40). Astrocytes also contribute to reproductive regulation
because they suppress postsynaptic currents in GnRH
neurons (41); produce RFRP-3, which inhibits GnRH
secretion and action (41–44); andmodulate GnRH release
in the median eminence (45–47).
Because SIRT1 has effects on neuroinflammation, we
investigated the role of SIRT1 in astrocytes in metabolic
and reproductive regulation. We created an inducible,
conditional deletion of the SIRT1 deacetylase domain or
conditional overexpression of wild-type SIRT1 in as-
trocytes by using a GFAP-Cre-ERTmouse and show that
the metabolic effect of SIRT1 is similar in astrocytes and
neurons, but the reproductive effect of SIRT1 in astro-
cytes is the opposite of that seen in neurons.
Methods
Animals
Mice having a tamoxifen (TAM)-inducible cre-recombinase
under the control of the human GFAP promoter (GCTF-cre),
which is expressed in astrocytes, were mated with mice con-
taining homozygous exon 4 floxed Sirt1 or floxed-STOP Sirt1
alleles. The resulting heterozygous/cre1 mice were then back-
crossed to the appropriate homozygous floxed Sirt1 mice.
Expression of cre deletes exon 4 of SIRT1, which encodes the
acetylase domain, creating functionally enzyme inactive mutant
(MUT) mice from the floxed allele, or causes overexpression of
wild-type SIRT1 by deletion of the transcriptional STOP se-
quence from the flox-STOP allele [SIRT1-overexpressing (OX)
mice]. The floxed-exon 4 and floxed-STOP Sirt1 mice were on a
C57BL/6 background, whereas the GCTF-cre mice were on a
Balb/c background. With our breeding scheme the final MUT
and OX mice would be 75% C57BL/6 and 25% Balb/c. Mice
were housed in a 12-hour light, 12-hour dark cycle. Body
weights were recorded weekly out to 90 days of age for both
sexes. Males and females had access to standard chow and
water ad libitum. Weaning and genotyping were performed at
21 days after birth. Genotyping was performed by PCR on
mouse-tail DNA with the primers listed in an online repository
(48). The MUT and OX mice were housed in the same cages as
their littermate controls. Mouse procedures conformed to the
Guide for Care and Use of Laboratory Animals of the US
National Institutes of Health and were approved by the Animal
Subjects Committee of the University of California, San Diego.
Induction of recombination
Mice were fed a TAM diet (400 mg TAM citrate per kg diet)
(TD.07262; Harlan Laboratories, Madison, WI) for 2 weeks
starting at 10 weeks of age to induce deletion in Cre1 mice
(MUT andOX).Mice were then returned to a normal chow diet
for another 2 weeks to allow the metabolism and excretion of
TAM before experiments proceeded. Cre-negative littermates
from either the MUT or OX breeding pairs were treated with
TAM and used as controls for TAM effects (Cre2/Tam), and
Cre-positive MUT or OX mice that did not receive TAM were
used as controls for Cre effects (Cre1/no-Tam). Analysis of the
data from the four control groups did not show any significant
differences, so the data from these control groups from both
genotypes were combined into a single wild-type control (CON)
group.
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Intraperitoneal glucose tolerance and insulin
tolerance tests
Mice at 5 months of age were subjected to IP glucose tol-
erance test (GTT) and insulin tolerance test (ITT). Mice were
fasted for 6 hours and then injected IP with glucose (1 g/kg body
weight) or human insulin (Novolin R, 0.4 U/kg body weight).
Tail vein blood glucose was measured with a glucose meter
(OneTouch Ultra; Bayer HealthCare, Tarrytown, NY) at 0, 15,
30, 45, 60, 90, and 120 minutes after injection.
Puberty onset and estrous cycles
Vaginal smear cytology was used to determine the estrous
cycle phases. For the estrous cycle assessment, 3-month-old
female mice were examined by vaginal cytology daily for
6 weeks. Samples were taken in the morning, vaginal fluid was
transferred onto a slide, and the slide was stained with
methylene blue (0.5% methylene blue and 1.6% potassium
oxalate in water) and then visualized under a light microscope
to assess reproductive stage. A cycle was defined as a day of
diestrus or metestrus, followed by a day of proestrus, then a
day of estrus. The length of the cycle was defined as the
number of days between successive days of proestrus in
normal diestrus-proestrus-estrus cycles.
Gene expression
Total RNA was extracted from whole brain after euthanasia
with RNA-Bee (Tel-Test Inc., Friendswood, TX) used according
to the manufacturer’s instructions. First-strand cDNA was
synthesized with a High Capacity cDNA synthesis kit (Applied
Biosystems, Waltham, MA). Targeted quantitative PCR (qPCR)
assays were run in 20 mL triplicate reactions on an MJ Research
Chromo4 instrument with iTaq SYBRGreen supermix (Bio-Rad,
Hercules, CA). For gene expression assays with 7-nLmicrofluidic
arrays (Fluidigm, San Francisco, CA), mRNAwas extracted with
RNA-Bee as before, but it was further purified with RNA pu-
rification kits (RNeasy; Qiagen, Germantown,MD) according to
the manufacturer’s instructions. Custom qPCR primers for a
panel of targets were designed and synthesized by Fluidigm for
their BioMark™ HD System. Gene expression levels were cal-
culated after normalization to the housekeeping gene m36B4 or
Gapdh via the 22ΔΔCT method and expressed as relative mRNA
levels compared with the control. Primers are listed in an online
repository (48).
24-hour fast
At 5 months of age, individually housed mice on normal
chow were fasted for 24 hours from 9:00 AM to 9:00 AM. Water
was provided ad libitum. Body was weighed, food intake was
measured, serum was collected, and glucose levels were mon-
itored before and after the fast.
High-fat diet feeding
At 4 months of age, groups of MUT, OX, and CON mice
were randomly assigned to a 60% high-fat diet (HFD) to create
DIO or to a matched 10% low-fat diet (LFD) (D12492 and
D12450B; Research Diets Inc., New Brunswick, NJ) for
10 weeks. Mice had ad libitum access to water. Major lipid
components of the HFD are derived from lard and include
20% palmitic acid, 11% stearic acid, 34% oleic acid, and
29% linoleic acid, resulting in 32% saturated fat, 36%
monounsaturated, and 32% polyunsaturated fat. Body weight
and food intake data were recorded weekly.
Tissue collection and histology
Testes, ovaries, brain, pituitaries, and other tissues were har-
vested at euthanasia for both histology and RNA extraction.
Testes were fixed in Bouin solution for 6 hours and ovaries in
formalin for 24 hours, followed by washing in 70% ethanol.
Paraffin-embedded sections (5 mm) were cut, dewaxed, and
stainedwith hematoxylin and eosin. Follicle number and stage and
corpora lutea number were counted on three to five sections from
ovaries from four to fivemice per group and are presented asmean
number per ovary (49). Follicle stages were defined as follows: 1°
as having a single layer of cuboidal granulosa cells (GCs), 2° as
having two or more layers of cuboidal GCs but no antrum, early
antral as having small patches of clear space between GCs, antral
as having clearly defined antrum, and atretic as having irregular
oocytemorphology.Ovarian sections examinedwere separated by
50 mm. Images were scanned on an Aperio ImageScope and
analyzed with the Imagescope software (Leica, Buffalo Grove, IL).
Gonadotropin measurements
Blood was collected from the tail vein of males and from
females at the beginning of diestrus, proestrus, estrus, and
metestrus for hormone analysis. Plasma LH and FSH levels were
measured byLuminex assay (catalog numberRPT86K;Millipore
Corp, Bedford, MA). Sensitivity of the assay is as follows: LH,
4.9 pg/mL, and FSH, 47.7 pg/mL, with an intra-assay coefficient
of variation of 15%. After 6, 12, and 20 weeks on the diets,
female mice were bled in the morning of diestrus and at the time
of the proestrus surge. Plasma LH and FSH levels were measured
by Luminex assay (catalog number MPTMAG-49K). Sensitivity
of the assays was as follows: LH, 4.9 pg/mL, FSH, 24.4 pg/mL.
To determine whether a mouse surged, diestrus values from all
lines were averaged (240 pg/mL), and any value greater than two
SDs above the average (.612pg/mL)was considered a surge. For
the GnRH and kisspeptin stimulation tests, tail vein blood was
collected before and 10 minutes (for GnRH) or 20 minutes (for
kisspeptin) after IP injection of 1 mg/kg GnRH or 30 nmol
kisspeptin-10, and gonadotropins were measured.
Insulin, leptin, and steroid measurements
Animals were fasted for 6 hours. Glucose was measured
with a glucose meter, blood drawn from the tail vein, and plasma
obtained. Fasting insulin (FI) and leptin were measured with the
Mouse Metabolic Kit from Meso Scale Discovery (catalog no.
K15124C-2; MSD, Rockville, MD). Sensitivity of the assay was
as follows: leptin, 43 pg/mL, insulin, 15 pg/mL; coefficient of
variation 6%and12%, respectively. Estrogen, progesterone, and
testosterone were measured with a Custom Steroid Hormone
Panel Kit (MSD). Sensitivity of the assay was as follows: estradiol
5 pg/mL, progesterone 70 pg/mL, testosterone 20 pg/mL, with
coefficients of variation 7%, 15%, and 22%, respectively.
In vivo leptin sensitivity test
We measured food intake in individually housed mice in-
jected IP with 0.5 mg/kg leptin (National Hormone and Peptide
Program, Harbor–University of California, Los Angeles) at 12-
hour intervals (6:00 AM and 6:00 PM) for a total of four con-
secutive doses. Food intake and body weight were measured for
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2 days before injection, for the 2-day injection period, and for
3 days afterward. A week later, the same process was repeated
except with PBS. Food intake after leptin injection was com-
pared with food intake after injections of saline.
Metabolic assessment
Six female mice per group (OX and MUT), matched for
body weight, were individually housed in a 12-chamber
Clinical Laboratory Animal Monitoring System with con-
trolled temperature, light, and feeding (Columbus In-
struments, Columbus, OH). Oxygen uptake, carbon dioxide
output, respiratory exchange ratio (RER), horizontal and
vertical ambulatory movement, feeding, and drinking
were measured over a 3-day period. Data from the first 12
hours during day 1 acclimation were excluded from further
analyses.
Statistical analysis
Data were analyzed by one-way or two-way ANOVA, or
Student t test as appropriate in Prism (Graph Pad, La Jolla, CA).
Pairwise comparisons were performed via Tukey post hoc tests
after the ANOVA. Normality was assessed by D’Agostino-
Pearson omnibus normality test. Results are expressed as
mean6 SEM and considered significant at P, 0.05. Statistical
differences are depicted with asterisks as *P , 0.05, **P ,
0.01, and ***P , 0.001. Supplemental material is provided in
an online data repository (48).
Results
Astrocyte SIRT1 alters food intake and body weight
Body weight and food intake were monitored daily
for 10 weeks starting at 13 weeks of age. The OX fe-
males were significantly heavier and the MUT signifi-
cantly lighter than the CON female mice (Fig. 1A). The
differences in body weight were associated with sig-
nificant differences in food intake (Fig. 1A inset), with
OX mice eating 50% more food and MUT eating 24%
less food than CON. Like the females, the OX males
were significantly heavier than CONmice, but theMUT
mice were not significantly different from the CONmale
mice (Fig. 1B). The differences in body weight were
again associated with significant but smaller differences
in food intake (Fig. 1B inset). Because of these differ-
ences in body weight and food intake, we measured
circulating leptin levels in 6-hour fasted mice. Leptin
levels were not altered in female mice (48) but were
significantly lower in MUT male mice (48). We per-
formed leptin sensitivity tests to see whether leptin was
able to suppress food intake. Female andmale mice were
injected with 0.5 mg/kg of leptin twice a day for 2 days
and food intake measured. Data were normalized to
the samemice receiving saline injections instead of leptin
the next week. All mice were leptin sensitive, and no
significant differences were observed between geno-
types (48).
Astrocyte SIRT1 alters glucose and insulin tolerance
At 5 months of age, mice were subjected to in-
traperitoneal GTT and ITT. For both experiments, mice
were fasted for 6 hours before the tests. During the GTT,
OX females were significantly less glucose sensitive than
CON mice, whereas the MUT mice were significantly
more glucose sensitive than CON mice (Fig. 1C). The
intolerance and sensitivity were confirmed by calcu-
lating the glucose excursion by area under the curve
(Fig. 1C inset). Like the females, OX males were also
glucose intolerant compared with CON males, but the
MUT mice were indistinguishable from CON (Fig. 1D).
The glucose intolerance in the OX males was confirmed
by area under the curve (Fig. 1D inset). The body weights
were no different between GTT groups for the males, but
the females were significantly different (48). To elimi-
nate any potential effect of body weight on glucose
tolerance, a subset of females with equal body weight was
compared, and the same differences inGTTwere observed
(48). Differences between the groups persisted if male and
female results were combined (48). Insulin and C-peptide
levels were measured in 6-hour fasted mice and compared
with fasting blood glucoses (FBGs). FBGs were lower in
MUT females and higher in OX males and females, as
before (Fig. 1E and 1F). FI levels were unchanged in fe-
male mice, but the MUT male mice had lower FI levels
(Fig. 1F). Homeostatic model assessment of insulin re-
sistance (HOMA-IR) calculations showed that both fe-
male (Fig. 1E) and male (Fig. 1F) MUT mice are insulin
sensitive. The C-peptide measurements showed that in-
sulin secretion is not altered between the genotypes
(Fig. 1E and 1F), suggesting that differences in insulin
levels are probably related to insulin clearance.
For the ITTs, the OX females had a significantly
higher mean FBG that dropped to lower values than
CON mice at 60 and 90 minutes (Fig. 2A). The MUT
females had lower mean FBG than CON mice, but
subsequent values were no different than those of CON
mice (Fig. 2A). Similar effects were seen in male mice,
with OX mice having higher mean FBG than CON or
MUTmice and the values dropping more markedly at 30
to 90 minutes (Fig. 2B). Calculation of the area above the
curve confirmed that the OXmice showed a greater drop
in blood glucose (Fig. 2A and 2B insets). When the data
were plotted as percentage basal, the female OX mice
were significantly more insulin sensitive and the MUT
significantly less sensitive than CON mice (Fig. 2C). The
MUT males were no different from the CON males, as
observed in the GTTs, but the OX males were signifi-
cantly more insulin sensitive than either CON or MUT
groups (Fig. 2D).
Because of the differences in food intake, we tested the
expression of hypothalamic hormones involved in the
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regulation of feeding in RNA extracted from whole
brain. Neuropeptide Y (Npy) showed both a genotype
and sex-dependent difference in expression by two-way
ANOVA (Fig. 2E), with higher expression in OX mice.
Agouti-related peptide (Agrp) also showed higher ex-
pression in OX males (Fig. 2E). The genes encoding two
other orexigenic peptides, Orexin A (Hcrt) and Nesfatin
(Nucb2), did not show any alterations (Fig. 2E). Ex-
pression of Sirt1was elevated in the female and male OX
mice, as expected (48). We also observed changes in
inflammatory gene expression. Expression of interleukin-
6 (Il6) was reduced in female MUT mice but elevated in
Figure 1. Overexpression of SIRT1 in astrocytes causes weight gain and glucose intolerance. (A) Body weights of female mice after TAM
induction up to 22 weeks of age. OX mice are in red, CON mice in white, and MUT mice in green (n 5 11, 48, and 12, respectively). Repeated-
measures two-way ANOVA indicated a significant time effect (P 5 0.016) and a significant genotype effect (P , 0.0001). Inset shows average
daily food intake. (B) Body weights and average food intake for male mice up to 22 weeks of age (n 5 10 for OX, n 5 46 for CON, and n 5
13 for MUT). Repeated-measures two-way ANOVA indicated a significant time effect (P 5 0.002) and a significant genotype effect (P , 0.0001)
for body weight. (C) GTTs performed in female mice at 3 months of age (n 5 11 for OX, n 5 45 for CON, and n 5 10 for MUT). Repeated-
measures two-way ANOVA indicated significant genotype and time effects and interaction (P , 0.0001). Inset shows area under the curve
(AUC). (D) GTTs performed in male mice at 3 months of age (n 5 10 for OX, n 5 41 for CON, and n 5 12 for MUT). Repeated-measures two-
way ANOVA indicated significant genotype and time effects and interaction (P , 0.0001). Inset shows AUC. (E) FBG, FI, HOMA-IR, and C-
peptide levels for 6-hour fasted female mice (n 5 21 for OX, n 5 22 for CON, n 5 19 for MUT). (F) FBG, FI, HOMA-IR, and C-peptide levels for
6-hour fasted male mice. Results are presented as mean 6 SEM. Asterisks indicate significance from post hoc testing. *P , 0.05; **P , 0.01;
***P , 0.001; ****P , 0.0001.
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male OX mice (48). The interleukin-12 p40 subunit
(Il12b) was reduced in female MUTmice (48), but tumor
necrosis factor a (Tnfa) was increased in male OX mice
(48). The results are consistent with the increased feeding
seen in the OX mice.
Mice overexpressing SIRT1 show altered activity
during the dark phase
Because the OX mice were glucose intolerant and
the MUT mice glucose sensitive, we subjected OX and
MUT mice to a metabolic assessment with continuous
monitoring over 3 days. Female mice (3 months old) were
used for this experiment, because theMUTmale mice did
not have a glucose-sensitive phenotype. The mice were
chosen to have the same body weight to eliminate body
weight as a variable. The mice did not lose a significant
amount of body weight during the study (48). The OX
mice showed stronger diurnal changes in rearing and
ambulatory activity (Fig. 3A and 3B) and showed an
anticipatory increase in activity before the onset of the
dark phase. When averaged over 12 hours, the OX mice
showed greater activity in both the dark and light phases
Figure 2. Overexpression of SIRT1 in astrocytes increases insulin sensitivity. (A) ITTs performed in female mice at 3 months of age (n 5 9 for
OX, n 5 36 for CON, n 5 9 for MUT). OX mice are in red, CON mice in white, and MUT mice in green. Repeated-measures two-way ANOVA
indicated significant time effect and time-genotype interaction (P , 0.0001) but no genotype effect. Inset shows area above the curve (AAC).
(B) ITTs performed in male mice at 3 months of age (n 5 7 for OX, n 5 39 for CON, n 5 9 for MUT). Repeated-measures two-way ANOVA
indicated significant time effect and genotype-time interaction (P , 0.001 and P , 0.0001) but no genotype effect. Inset shows AAC. (C) ITTs in
female mice presented as percentage basal fasting glucose level. Repeated-measures two-way ANOVA indicated significant time effect and
genotype effects (P , 0.0001) and interaction (P , 0.001). (D) ITTs in male mice presented as percentage basal fasting glucose level. Repeated-
measures two-way ANOVA indicated significant time effect and genotype effects (P , 0.0001 and P , 0.01) and interaction (P , 0.001). (E)
Hypothalamic orexigenic gene expression for neuropeptide Y (Npy), agouti-related peptide (Agrp), orexin-A (Hcrt), and nesfatin (Nucb2) in MUT,
CON, and OX mice. Gene expression from female mice (n 5 8 for MUT, n 5 27 for CON, and n 5 6 for OX) and male mice (n 5 7 for MUT,
n 5 28 for CON, and n 5 7 for OX) by qPCR. Results are presented as mean 6 SEM. Asterisks indicate significance from post hoc testing. *P ,
0.05; **P , 0.01; ***P , 0.001.
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(48). Interestingly, the cage temperature was elevated in
the OX mice and did not show the normal diurnal
changes (Fig. 3C), which may reflect the increased
physical activity in the OX mice. The RER was un-
changed between the genotypes (Fig. 3D), but the MUT
mice have a significantly lower mean RER during the
light phase (48), indicating that they are preferentially
using oxidizing lipid. Oxygen consumption (VO2) was
significantly different between the genotypes, but car-
bon dioxide production (VCO2) was not (Fig. 3E and
3F); both were lower in the OXmice during the light and
dark phases (48). Mean food and water intake was not
altered by genotype during the study (Fig. 3G and 3H).
Thus the OX mice showed greater activity and heat
generation that partially compensated for the elevated
food intake.
Figure 3. Metabolic cage studies of female OX and MUT mice. OX mice (n 5 6) are shown in red and MUT mice (n 5 6) in green. Graphs show
diurnal patterns over 24 hours measured per minute for physical activity or per 13-minute interval for other measurements. Horizontal black bar
indicates period of lights off (6:00 PM to 6:00 AM). Time of day is indicated on the x-axis. (A) Rearing activity over 24 hours. Repeated-measures two-
way ANOVA indicated significant genotype and time effects (P , 0.0001) and interaction (P , 0.0001). (B) Ambulatory activity over 24 hours.
Repeated-measures two-way ANOVA indicated significant genotype and time effects (P , 0.0001) and interaction (P , 0.0001). (C) Cage
temperature over 24 hours. Repeated-measures two-way ANOVA indicated significant genotype and time effects (P , 0.0001) and interaction (P ,
0.0001). (D) RER over 24 hours. Repeated-measures two-way ANOVA indicated significant time effect (P , 0.0001) and a significant interaction
(P , 0.0001) but no genotype effect. (E) Volume O2 consumed (VO2) over 24 hours. Repeated-measures two-way ANOVA indicated significant time
(P , 0.0001) and genotype (P , 0.01) effects and a significant interaction (P , 0.0001). (F) Volume CO2 produced (VCO2) over 24 hours.
Repeated-measures two-way ANOVA indicated significant genotype (P , 0.05) and time effects (P , 0.0001) and interaction (P , 0.01) but no
post hoc significant differences between genotypes. (G) Food intake over 24 hours. Repeated-measures two-way ANOVA indicated significant time
effect (P , 0.0001) but no genotype effect or interaction. (H) Water intake over 24 hours. Repeated-measures two-way ANOVA indicated significant
genotype and time effect (P , 0.0001), no genotype effect, but a significant interaction (P , 0.01). Results are presented as mean 6 SEM. Asterisks
indicate significant differences between genotypes after post hoc testing. *P , 0.05; ****P , 0.0001.
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Astrocyte SIRT1 does not alter the response to a
24-hour fast
Because SIRT1 may play a role in the effects of calorie
restriction, we tested whether the SIRT1 in astrocytes
alters the response to fasting. Individually housed 5-
month-old female (Fig. 4A–4C) and male (Fig. 4D–4F)
mice were subjected to a 24-hour fast. Body weight, food
intake, and blood glucose levels were measured 2 days
before, during, and 2 days after the fast. All genotypes in
both female andmale mice showed a drop in body weight
after the 24-hour fast that recovered within 24 hours
(Fig. 4A and 4D). Differences in weights between the
genotypes were maintained during the 24-hour fast.
Glucose levels dropped equivalently during the 24-hour
fast in both female and male mice but still showed the
genotypic differences observed before (Fig. 4B and 4E).
The glucose levels returned to normal 24 hours later. All
mice showed the expected rebound eating for the first 24
hours after the fast, which returned to normal after
2 days (Fig. 4C and 4F). These results suggested that
genetic manipulation of Sirt1 in astrocytes did not alter
the response to fasting.
Astrocyte SIRT1 causes more weight gain in female
mice, but not male mice, on HFD
Although caloric restriction leads to an increase in
SIRT1, HFD has been associated with low SIRT1 ac-
tivity. So mice were randomly selected at 17 weeks of age
for either an HFD (60 cal%) or a matched LFD (10 cal
%). Body weight and food intake were measured weekly
for 10 weeks, and mice were euthanized at 27 weeks.
Females on the LFD maintained their body weight, al-
though the OX females showed slightly greater separa-
tion from the other two genotypes (Fig. 4G). The weekly
food intake reflected the difference in body weight
(Fig. 4G inset). Females on the HFD showed significant
differences in weight gain (Fig. 4H). After 4 weeks of
HFD the OX females weighed significantly more than the
MUT (Fig. 4H), and their weight continued to diverge
from that of the CON mice over the next 6 weeks. The
MUT mice initially gained weight at the same rate as the
CON mice, but the weights started to diverge after
5 weeks, and theMUTmice gained less weight thereafter,
although they had not reached significance at the end of
the study (Fig. 4H). The differences in weight gain were
again reflected in differences in food intake between the
genotypes (Fig. 4G and 4H insets). No differences in
body weight were observed for male mice on LFD or
HFD (Fig. 4I and 4J), although there were small but
significant differences in food intake between genotypes
on HFD (Fig. 4G inset). These results indicated that
astrocyte SIRT1 influenced the development of obesity in
female mice.
Astrocyte SIRT1 promotes and lack of SIRT1 impairs
estrus cycles
To evaluate the reproductive role of SIRT1 in astro-
cytes, estrous cycles were documented in postpubertal
females, over the course of 6 weeks from 14 to 20 weeks
of age. The OX mice showed a greater number of cycles
during this period than MUT or CON mice (Fig. 5A),
with more days in diestrus and fewer days in estrus
compared with MUT mice (Fig. 5B). We measured FSH
and LH levels at each estrous stage. No differences were
seen at diestrus, early proestrus, or estrus between the
genotypes (Fig. 5C). All genotypes showed an increase
in LH during the afternoon of proestrus (Fig. 5D), but
when mice were divided into those with a detectable LH
surge and those without, significant differences in the
number of surges were observed (Fig. 5D). Roughly
50% of the CON mice surged (11/24) but only 12% of
the MUT mice (1 out of 7), and 88% of OX mice surged
(7/8). The FSH values were also significantly different
(Fig. 5E). The OXmice had lower FSH values in diestrus
and early proestrus and showed a clear increase during
late proestrus and estrus, whereas theMUTmice did not
show a difference in FSH at any point of the cycle. The
CON mice showed the expected increase in FSH during
estrus.
Because the LH surge appeared to be impaired in
MUT females, we performed a GnRH stimulation test.
LH and FSH were measured before and 10 minutes
after an IP injection of GnRH (1 mg/kg). The pituitary
response was intact in all genotypes as the LH in-
creased in response to the GnRH bolus (48). We
verified this finding by repeating the experiment in
male mice (48). FSH did not change in response to
GnRH in any genotype or sex (48). We then tested
whether the GnRH neurons were responsive by
performing a kisspeptin stimulation test in female mice.
LH and FSH were measured before and 20 minutes
after an IP injection of kisspeptin 10 (30 nmol). All
three genotypes showed the expected rise in LH (48),
with no change in FSH (48).
We then tested the expression of hypothalamic hor-
mones involved in the regulation of reproduction. Ex-
pression of the genes encoding kisspeptin (Kiss1) and
RFRP3 (Npvf) were altered inMUT andOX female mice,
but genes encoding GnRH (Gnrh1), oxytocin (Oxt),
dynorphin (Pdyn), and neurokinin B (Tac2) were un-
changed (Fig. 5F and 5G).
We assessed follicle development and ovulation by
examining ovarian histology after euthanasia. The
ovaries from MUT mice were significantly smaller than
those of CON or OX mice (Fig. 6A and 6B) and had a
lower number of antral follicles and corpora lutea and a
higher number of atretic follicles (Fig. 6C) consistent
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with impaired follicle development and ovulation. Es-
trogen levels were unchanged in the female mice, and
progesterone levels mirrored the LH surges, with lower
levels in the MUT mice (Fig. 6D). No differences
in testicular morphology were observed in the male
mice (48).
Figure 4. Overexpression of SIRT1 does not alter the response to fasting but increases weight gain in females on an HFD. OX mice are in red, CON
mice in white, and MUT mice in green. (A) Body weight for female mice before, during, and after a 24-hour fast (n 5 10 for OX, n 5 16 for CON,
n 5 10 for MUT). (B) Blood glucose before, during, and after a 24-hour fast. (C) Food intake before and for 2 days after a 24-hour fast. (D) Body
weight for male mice before, during, and after a 24-hour fast (n 5 10 for OX, n 5 16 for CON, n 5 10 for MUT). (E) Blood glucose before, during,
and after a 24-hour fast. (F) Food intake before and for 2 days after a 24-hour fast. Repeated-measures two-way ANOVA indicated significant time
and genotype effects (P , 0.0001) for weight and blood glucose and a significant time effect (P , 0.0001) and genotype effect (P , 0.05) for food
intake for both female and male mice. (G) Body weight of female mice on an LFD for 10 weeks (n 5 5 for OX, n 5 10 for CON, n 5 5 for MUT).
Repeated-measures two-way ANOVA indicated significant time and genotype (P , 0.001) effects. Inset shows mean daily food intake. (H) Body
weight of female mice on an HFD for 10 weeks (n 5 7 for OX, n 5 12 for CON, n 5 7 for MUT). Repeated-measures two-way ANOVA indicated
significant time effect and genotype-time interaction (P , 0.0001). Inset shows mean daily food intake. (I) Body weight of male mice on an LFD for
10 weeks (n 5 7 for OX, n 5 11 for CON, n 5 5 for MUT). Inset shows mean daily food intake. (J) Body weight of male mice on an HFD for 10
weeks (n 5 6 for OX, n 5 10 for CON, n 5 5 for MUT). Repeated-measures two-way ANOVA indicated no significant time and genotype effects
for weight on LFD or HFD for male mice. Inset shows mean daily food intake. Data are shown as mean 6 SEM. Asterisks indicate significance by
post hoc testing as indicated. *P , 0.05; **P , 0.01; ***P , 0.001; ****P , 0.0001.
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Discussion
Previously, loss of SIRT1 enzyme activity in neurons did
not alter glucose metabolism in male mice but increased
insulin sensitivity in the brain and periphery and partially
protected mice fromHFD-induced obesity (50). In female
mice we observed that similar loss of SIRT1 enzyme
activity in neurons improved glucose tolerance by GTT.
Figure 5. Overexpression of SIRT1 increases estrous cycling and ovulation in female mice. OX mice are in red, CON mice in white, and MUT mice in green. (A)
Number of estrous cycles over 28 days of cycling by vaginal cytology (n 5 10 for OX, n 5 47 for CON, n 5 12 for MUT). (B) Percentage of days spent in each
stage of the estrous cycle over 28 days (n 5 10 for OX, n 5 47 for CON, n 5 12 for MUT). Two-way ANOVA indicated significant stage effect (P , 0.0001)
and significant interaction of stage and genotype (P , 0.0001). (C) LH levels during diestrus, the morning of proestrus, and the morning of estrus (n 5 6 for OX,
n 5 20 for CON, n 5 8 for MUT). Two-way ANOVA indicated no significant differences. (D) LH levels during the afternoon of proestrus (n 5 6 for OX, n 5 20
for CON, n 5 8 for MUT). Asterisks indicate a significant difference in the number of LH surges by Fisher exact test. (E) FSH levels during diestrus, the morning of
proestrus, the afternoon of proestrus, and the morning of estrus (n 5 6 for OX, n 5 20 for CON, n 5 8 for MUT). Two-way ANOVA indicates significant stage
effect (P 5 0.002) but no significant genotype effect or interaction. (F) Hypothalamic Kiss1 and Gnrh1 expression in MUT, CON, and OX mice by qPCR. (G)
Hypothalamic neuropeptide gene expression for MUT, CON, and OX mice by qPCR. n 5 8 for MUT. n 5 27 for COM, n 5 6 for OX for qPCR data. Results are
presented as mean 6 SEM. Asterisks indicate significance from post hoc testing as indicated. *P , 0.05; **P , 0.01; ***P , 0.001; ****P , 0.0001.






/endo/article-abstract/160/6/1547/5479348 by Endocrine Society M
em
ber Access 3 user on 28 June 2019
Additionally, we observed that overexpression of wild-
type SIRT1 in neurons in either female or male mice
impaired glucose tolerance, which is consistent with the
improved glucose tolerance in the deacetylase-inactive
mutant mice, but it did not have a major effect on food
intake (50). Consistent with a role for SIRT1 in the re-
sponse to caloric restriction, neuronal overexpression of
SIRT1 rendered the mice more sensitive to the metabolic
effects of caloric restriction. In contrast to those results, in
this study we found that genetic manipulation of SIRT1
in astrocytes altered feeding behavior, with loss of
SIRT1 enzyme activity decreasing food intake and SIRT1
overexpression increasing food intake in both males and
females, which was unrelated to leptin. This effect
resulted in significant differences in body weight and
significant differences in glucose tolerance, although we
do not believe that the altered glucose tolerance simply
reflected the differences in body weight, because the
differences persisted if weight-matched subgroups were
compared. The more glucose-tolerant MUT mice had
lower FBG and lower FI, leading to a lower HOMA-IR
that agreed with the improved glucose tolerance. The
glucose tolerance with SIRT1 overexpression or in-
activation in astrocytes was consistent with the GTT
effects seen in neurons, but the alterations in insulin
tolerance in the astrocyte SIRT1 mice were not observed
in the neuronal mutants (50). The insulin tolerance was
paradoxical given the GTTs. This effect may be related to
Figure 6. SIRT1 inactivation reduces ovary size and number of corpora lutea. OX mice are in red, CON mice in white, and MUT mice in green.
(A) Ovarian morphology. Representative hematoxylin and eosin stained sections of ovaries obtained at euthanasia. (B) Quantification of ovarian
cross-sectional area for MUT (n 5 9), CON (n 5 35), and OX (n 5 9) ovaries. (C) Quantification of follicle stage and corpora lutea. Number of
follicles at each stage per section for MUT (n 5 9), CON (n 5 9), and OX (n 5 9) mice. (D) Estrogen and progesterone levels during diestrus,
proestrus, and estrus. Data are shown as mean 6 SEM. Asterisks indicate significance by post hoc testing. *P , 0.05; **P , 0.01; ***P ,
0.001. AF, antral follicle; CL, corpora lutea.
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altered insulin clearance, because C-peptide levels were
not changed, indicating that insulin secretion was nor-
mal. During metabolic testing, the OX mice were more
active, generatedmore heat but had a lower VO2 than the
MUTmice, suggesting more energy consumption but less
efficient fuel utilization. Food intake was not different
between genotypes in the singly housed metabolic cage
study, but the overexpressing mice ate more food under
normal housing conditions (nearly twice as much for
females) that probably compensated for the greater en-
ergy consumption and allowed greater weight gain.
Astrocytic SIRT1, unlike neuronal SIRT1, did not appear
to influence the response to fasting.
How do astrocytes contribute to metabolic regulation?
Astrocytes play an essential role in the deliverance of
glucose, oxygen, and other nutrients to neurons (31, 51,
52). Astrocyte signaling via IKK/NF-kB is necessary for
DIO and hypothalamic inflammation and for increased
food intake during acute high-fat feeding (39, 53). As-
trocytes can also control food intake by depressing
ghrelin-evoked hyperphagia but facilitating leptin-induced
anorexia, by inhibiting Agrp neurons (54). As a result,
mice lacking the leptin receptor in astrocytes are hyper-
phagic and gain more weight on HFDs (38, 55), whereas
mice lacking the insulin receptor in astrocytes are meta-
bolically normal but prone to anxiety and depressive-like
behavior (56). How is SIRT1 linked to these astrocytic
pathways? SIRT1 has been suggested to impair NF-kB
signaling in the hypothalamus (57), and astrocyte NF-kB
signaling is necessary for DIO (39). Consistent with this
model, expression of the deacetylase-deficient SIRT1
mutant protected female mice from DIO, whereas SIRT1
overexpression increased DIO. We observed increases in
hypothalamic Il6 and Tnfa expression, particularly in the
SIRT1-overexpressing mice, which would be consistent
with the glucose intolerant phenotype. Thus SIRT1 in
astrocytes could play a role in feeding behavior and
glucosemetabolism through suchmechanisms, but further
studies will be needed to dissect the pathways involved.
At the female reproductive level, overexpression of
SIRT1 increased the number of estrous cycles, increased
time in diestrus, and decreased time in estrus. A greater
proportion of overexpressing mice showed LH surges,
whereas only one deacetylase-deficient mouse showed an
LH surge. The SIRT1-deficient mice also showed reduced
corpora lutea upon examination of the ovaries, which is
consistent with decreased ovulation. These mice also did
not show any changes in FSH levels throughout the estrous
cycle that may explain the lack of progression into the next
follicular cycle. Hypothalamic Kiss1 levels were reduced in
the deacetylase-deficient SIRT1 mice, but the GnRH neu-
rons showed a normal response to exogenous kisspeptin-
10, indicating that the defect probably lies upstream of the
GnRH neuron, either at the Kiss1 neurons or further up-
stream.Whether or how astrocytes influenceKiss1 neurons
is not known but warrants further investigation. In sum-
mary, SIRT1 in astrocytes has divergent effects to impair
glucose metabolism and increase sensitivity to DIO in fe-
males but to improve reproductive function by increasing
the frequency of LH surges and ovulation.
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